GLYCO-IBD: Glycans as new immunomodulators in inflammatory bowel disease: An opportunity for new therapeutic strategies. (Q2905968): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in pt, en, fr, de, nl, es, et, lt, hr, el, sk, fi, pl, hu, cs, lv, ga, sl, bg, mt, da, ro, sv, it, and other parts: Adding translations: et, lt, it, fr, hr, el, en, sk, fi, pl, hu, nl, cs, lv, ga, sl, es, bg, mt, pt, da, ro, de, sv,) |
(Changed label, description and/or aliases in en, pt: Fixing missing labels.) |
||
| label / pt | label / pt | ||
GLYCO-IBD .: Glicanos como novos imunomoduladores na doença inflamatória intestinal: uma oportunidade para novas estratégias terapêuticas. | |||
| label / en | label / en | ||
GLYCO-IBD: Glycans as new immunomodulators in inflammatory bowel disease: An opportunity for new therapeutic strategies. | |||
Revision as of 04:56, 27 August 2022
Project Q2905968 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | GLYCO-IBD: Glycans as new immunomodulators in inflammatory bowel disease: An opportunity for new therapeutic strategies. |
Project Q2905968 in Portugal |
Statements
166,566.0 Euro
0 references
195,960.0 Euro
0 references
85.0 percent
0 references
1 July 2016
0 references
31 December 2019
0 references
IPATIMUP-INSTITUTO DE PATOLOGIA E IMUNOLOGIA MOLECULAR DA UNIVERSIDADE DO PORTO
0 references
Q2993205 (Deleted Item)
0 references
Identifiers
POCI-01-0145-FEDER-016601
0 references